INVESTIGATIONS OF YM155, AN INHIBITOR OF SURVIVIN, AS A MOLECULAR MULTI-TARGETED AGENT FOR RENAL CELL CARCINOMA
Ph.D
Saved in:
Main Author: | SIM MEI YI |
---|---|
Other Authors: | PHARMACY |
Format: | Theses and Dissertations |
Language: | English |
Published: |
2016
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/124184 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
Similar Items
-
GROWTH INHIBITORY DIXONAPHTHOIMIDAZOLIUMS RELATED TO YM155: SYNTHESIS AND MECHANISTIC INVESTIGATIONS
by: HO SI HAN, SHERMAN
Published: (2015) -
Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK/T cell lymphoma revealed by gene expression profiling
by: Ng, S.-B., et al.
Published: (2014) -
The over-expression of survivin enhances the chemotherapeutic efficacy of YM155 in human hepatocellular carcinoma
by: Xia H., et al.
Published: (2020) -
The Role of Serum Amyloid A in atherosclerosis
by: TAN SI ZHEN
Published: (2012) -
Anti-survivin effect of the small molecule inhibitor YM155 in RCC cells is mediated by time-dependent inhibition of the NF-?B pathway
by: Sim M.Y., et al.
Published: (2019)